65,437 trials
Hematopoietic Cell Transplantation Recipient · Recurrent Diffuse Large B-Cell Lymphoma · Recurrent Grade 1 Follicular Lymphoma
Primary: Maximum Tolerated Dose of Venetoclax Defined to be the Dose Cohort Below Which 3 Out of 6 Patients Experience Dose Limiting Toxicities or the Highest Dose Cohort of 1200…
Alzheimer's Disease · Healthy Non-elderly and Elderly Adults
Primary: Number of Participants With Serious AEs, TEAEs That Lead to Premature Discontinuation, Abnormal Laboratory Test Results, Abnormal ECG Readings. — 0; 0; 0; 0 Participants
Xerostomia Following Radiotherapy · Xerostomia Following in Neck or Head After Cancer Surgery · Other Late Sequelae Following Radiotherapy and Cancer Surgery in Neck or Head
Primary: Xerostomia Questionnaire — 8; 46.4 score on a scale
Dry Eye
Primary: Change From Baseline in Ocular Surface Fluorescein Staining Score at Day 28 — -2.1; -1.5 score on a scale
Hypoxic-Ischemic Encephalopathy · Brain Ischemia Hypoxia
Primary: Detection of Brain Perfusion Abnormalities Using Contrast-enhanced Ultrasound — 1; 0 Participants
Breast Ptosis
Primary: Independent Photographic Review of Before and After Images Compared to Baseline Compared to D180. — 11 Participants
Follicular Lymphoma
Primary: Complete Response Rate (CR/CRu) at 120 Weeks by Independent Central Review — 48.1; 53.0 Percent of participants — p=0.128
Educational Activities
Primary: Decisional Conflict for Getting Tested for COVID-19 — 3.89; 3.96 score on a scale — p=0.4471
Intubation, Intratracheal
Primary: Modified Intubation Difficulty Scale Score (mIDS) — 1; 0 score on a scale range of 0 to 10 number
Lung Cancer
Primary: Feasibility of Enrollment — 75 Participants
Attention Deficit/Hyperactivity Disorder
Primary: A Comparison of the Change in Mean ADHD Rating Scale (ADHD-RS) Results From Baseline to End of Treatment Between Active and Placebo Treatments. — -18.6; -4.4; -17.6…
SARS-CoV-2 Infection · Influenza A · Influenza B
Primary: Qualitative Detection of RNA From SARS-CoV-2, Influenza A, and Influenza B ; Positive Percent Agreement Performance Comparison of Candidate Device (Metrix) vs…
Myopia
Primary: The Correlation of White-to-white Measurements Between Biometric Devices. — 0.89; 0.65; 0.53; 0.60 Pearson correlation r
Atopic Dermatitis Eczema · Atopic Dermatitis · Eczema
Primary: Change in Disease Severity as Measured by the Eczema Area and Severity Index (EASI) — 4.81; 4.93; 2.70; 2.76 score on a scale
Social Anxiety Disorder
Primary: Change From Baseline in the Social Phobia Diagnostic Questionnaire (SPDQ) at Post-treatment — -9.60; -4.46 score on a scale — p=< 0.05